Noncrystalline uric acid inhibits proteoglycan and glycosaminoglycan synthesis in distal tubular epithelial cells (MDCK)

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 10, 2010, Pages 957-963

  Borges, F T ^a   Dalboni, M A ^a   Michelacci, Y M ^a   Schor, N ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Glycosaminoglycan; Lipopolysaccharide; MDCK; Noncrystalline uric acid; Proteoglycan

Indexed keywords

ACRIDINE ORANGE; CALCIUM OXALATE; CORE PROTEIN; CYCLOOXYGENASE 2; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROTEOGLYCAN; URIC ACID;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; GLYCOSAMINOGLYCAN METABOLISM; HYPERURICEMIA; KIDNEY DISTAL TUBULE; NEPHROLITHIASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 78149258513     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500095     Document Type: Article

References (31)

1. Herring LC. Observations on the analysis of ten thousand urinary calculi. J Urol 1962; 88: 545-562.
2. Daudon M, Donsimoni R, Hennequin C, Fellahi S, Le Moel G, Paris M, et al. Sex- and age-related composition of 10,617 calculi analyzed by infrared spectroscopy. Urol Res 1995; 23: 319-326.
3. Mandel NS, Mandel GS. Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence. J Urol 1989; 142: 1513-1515.
4. Yu TF. Nephrolithiasis in patients with gout. Postgrad Med 1978; 63: 164-170.
5. Moe OW, Abate N, Sakhaee K. Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31: 895-914.
6. Daudon M, Hennequin C, Bader C, Jungers P, Lacour B, Druecke T. Inhibitors of crystallization. Adv Nephrol Necker Hosp 1995; 24: 167-216.
7. Coe FI, Parks JH, Nakagawa Y. Protein inhibitors of crystallization. Semin Nephrol 1991; 11: 98-109.
8. Michelacci YM, Glashan RQ, Schor N. Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney Int 1989; 36: 1022-1028.
9. Angell AH, Resnick MI. Surface interaction between gly-cosaminoglycans and calcium oxalate. J Urol 1989; 141: 1255-1258.
10. Pereira DA, Aguiar JA, Hagiwara MK, Michelacci YM. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome. Biochim Biophys Acta 2004; 1672: 1-11.
11. Groffen AJ, Veerkamp JH, Monnens LA, van den Heuvel LP. Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane. Nephrol Dial Transplant 1999; 14: 2119-2129.
12. Schaefer L, Grone HJ, Raslik I, Robenek H, Ugorcakova J, Budny S, et al. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, f-bromodulin, and lumican. Kidney Int 2000; 58: 1557-1568.
13. Michelacci YM, Cadaval RA, Rovigatti RM, Kohlman O. Renal and urinary glycosaminoglycans in an experimental model of chronic renal failure in rats. Exp Nephrol 2001; 9: 40-48.
14. Cadaval RA, Kohlman O, Michelacci YM. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus. Glycobiology 2000; 10: 185-192.
15. Eguchi Y, Inoue M, Iida S, Matsuoka K, Noda S. Heparan sul-fate (HS)/heparan sulfate proteoglycan (HSPG) and bikunin are up-regulated during calcium oxalate nephrolithiasis in rat kidney. Kurume Med J 2002; 49: 99-107.
16. Chikama S, Iida S, Inoue M, Kawagoe N, Tomiyasu K, Mat-suoka K, et al. Role of heparan sulfate proteoglycan (syn-decan-1) on the renal epithelial cells during calcium oxalate monohydrate crystal attachment. Kurume Med J 2002; 49: 201-210.
17. Erickson AC, Couchman JR. Basement membrane and interstitial proteoglycans produced by MDCK cells correspond to those expressed in the kidney cortex. Matrix Biol 2001; 19: 769-778.
18. Farell G, Huang E, Kim SY, Horstkorte R, Lieske JC. Modulation of proliferating renal epithelial cell affnity for calcium oxalate monohydrate crystals. J Am Soc Nephrol 2004; 15: 3052-3062.
19. Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS, Taub M. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB. Am J Physiol Renal Physiol 2007; 292: F373-F381.
20. Borges FT, Michelacci YM, Aguiar JA, Dalboni MA, Garofalo AS, Schor N. Characterization of glycosaminoglycans in tubular epithelial cells: calcium oxalate and oxalate ions effects. Kidney Int 2005; 68: 1630-1642.
21. Pinhal MA, Silva IF, Lee TC, Dietrich CP, Nader HB. Binding of heparin and compound Y to endothelial cells stimulates the synthesis of an antithrombotic heparan sulfate proteo-glycan. Braz J Med Biol Res 1994; 27: 2191-2195.
22. Dietrich CP, Dietrich SM. Electrophoretic behaviour of acidic mucopolysaccharides in diamine buffers. Anal Biochem 1976; 70: 645-647.
23. Soriano ES, Campos MS, Michelacci YM. Effect of epithelial debridement on glycosaminoglycan synthesis by human corneal explants. Clin Chim Acta 2000; 295: 41-62.
24. Hadad SJ, Michelacci YM, Schor N. Proteoglycans and glycosaminoglycans synthesized in vitro by mesangial cells from normal and diabetic rats. Biochim Biophys Acta 1996; 1290: 18-28.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
26. Grover PK, Ryall RL. Urate and calcium oxalate stones: from repute to rhetoric to reality. Miner Electrolyte Metab 1994; 20: 361-370.
27. Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysi-ologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002; 62: 971-979.
28. Grases F, Sanchis P, Isern B, Perello J, Costa-Bauza A. Uric acid as inducer of calcium oxalate crystal development. Scand J Urol Nephrol 2007; 41: 26-31.
29. Khan SR. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995; 23: 71-79.
30. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562.
31. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991; 266: 8604-8608.